Is proton beam therapy ready for single fraction spine SBRS? – a feasibility study to use spot-scanning proton arc (SPArc) therapy to improve the robustness and dosimetric plan quality

References

• Wu G, Shi Z, Chen Y, et al. A sparse representation-based radiomics for outcome prediction of higher grade gliomas. Med Phys. 2019;46(1):250–261.
   PubMed Web of Science ®Google Scholar
• Ecker RD, Endo T, Wetjen NM, et al. Diagnosis and treatment of vertebral column metastases. Mayo Clin Proc. 2005;80(9):1177–1186.
   PubMed Web of Science ®Google Scholar
• Joaquim AF, Ghizoni E, Tedeschi H, et al. Stereotactic radiosurgery for spinal metastases: a literature review. Einstein. 2013;11(2):247–255.
   PubMedGoogle Scholar
• Rief H, Chaudhri N, Tonndorf-Martini E, et al. Intensity-modulated radiotherapy versus proton radiotherapy versus carbon ion radiotherapy for spinal bone metastases: a treatment planning study. J Appl Clin Med Phys. 2015;16(6):186–194.
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Ozhasoglu C, et al. Radiosurgery for spinal metastases. Spine. 2007;32:193–199.
   Google Scholar
• Gerszten PC, Mendel E, Yamada Y. Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes? Spine. 2009;34(22 Suppl):S78–S92.
   PubMed Web of Science ®Google Scholar
• Ryu S, James J, Gerszten P, et al. RTOG 0631 phase II/III study of image-guided stereotactic radiosurgery for localized spine metastases: phase II results. Int J Radiat Oncol. 2011;81(2):S131–S132.
   PubMed Web of Science ®Google Scholar
• Ryu S, Yin FF, Rock J, et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer. 2003;97(8):2013–2018.
   PubMed Web of Science ®Google Scholar
• Li X, Kabolizadeh P, Yan D, et al. Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy. Radiat Oncol. 2018;13(1):35.
   PubMed Web of Science ®Google Scholar
• Ding X, Li X, Qin A, et al. Have we reached proton beam therapy dosimetric limitations? – a novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer. Acta Oncol. 2018;57(3):435–437.
   PubMed Web of Science ®Google Scholar
• Ding X, Li X, Qin A, et al. Redefine the role of range shifter in treating bilateral head and neck cancer in the era of intensity modulated proton therapy. J Appl Clin Med Phys. 2018;19:749–755.
   PubMed Web of Science ®Google Scholar
• Dvorak P, Georg D, Bogner J, et al. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions. Int J Radiat Oncol. 2005;61(5):1572–1581.
   PubMed Web of Science ®Google Scholar
• Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):4078–4101.
   PubMed Web of Science ®Google Scholar
• Nill S, Tücking T, Münter MW, et al. Intensity modulated radiation therapy with multileaf collimators of different leaf widths: a comparison of achievable dose distributions. Radiother Oncol. 2005;75(1):106–111.
   PubMed Web of Science ®Google Scholar
• MacEwan I, Chou B, Mifflin R, et al. Passively scattered proton stereotactic body radiation therapy for spine metastasis: a dosimetric analysis. Int J Radiat Oncol. 2016;96(2):E675–E676.
   Web of Science ®Google Scholar
• Bhatt AD, Jacobson A, Lee RY, et al. High-dose proton beam-based radiation therapy in the management of extracranial chondrosarcomas. Int J Part Ther. 2016;3(3):373–381.
   Google Scholar
• Schuemann J, Dowdell S, Grassberger C, et al. Site-specific range uncertainties caused by dose calculation algorithms for proton therapy. Phys Med Biol. 2014;59(15):4007–4031.
   PubMed Web of Science ®Google Scholar
• Paganetti H, Yu CX, Orton CG. Photon radiotherapy has reached its limit in terms of catching up dosimetrically with proton therapy: point/counterpoint. Med Phys. 2016;43(8Part1):4470–4472.
   PubMed Web of Science ®Google Scholar
• Ding X, Li X, Zhang JM, et al. Spot-scanning proton arc (SPArc) therapy: the first robust and delivery-efficient spot-scanning proton arc therapy. Int J Radiat Oncol Biol Phys. 2016;96(5):1107–1116.
   PubMed Web of Science ®Google Scholar
• Ryu S, Pugh SL, Gerszten PC, et al. RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol. 2014;4(2):76–81.
   PubMedGoogle Scholar
• Elibe E, Boyce-Fappiano D, Ryu S, et al. Stereotactic radiosurgery for primary tumors of the spine and spinal cord. J Radiosurgery SBRT. 2018;5:107–113.
   PubMed Web of Science ®Google Scholar
• Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol. 2002;53(2):407–421.
   PubMed Web of Science ®Google Scholar
• Liu G, Li X, Zhao L, et al. A novel energy sequence optimization algorithm for efficient spot-scanning proton arc (SPArc) treatment delivery. Acta Oncol. 2020;59:1178–1185.
   PubMed Web of Science ®Google Scholar
• Kang KH, Okoye CC, Patel RB, et al. Complications from stereotactic body radiotherapy for lung cancer. Cancers. 2015;7(2):981–1004.
   PubMed Web of Science ®Google Scholar
• Quan EM, Li X, Li Y, et al. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol. 2012;83(4):1169–1178.
   PubMed Web of Science ®Google Scholar
• Aoyama H, Westerly DC, Mackie TR, et al. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol. 2006;64(3):962–967.
   PubMed Web of Science ®Google Scholar
• Qin A, Gersten D, Liang J, et al. A clinical 3D/4D CBCT-based treatment dose monitoring system. J Appl Clin Med Phys. 2018;19(6):166–176.
   PubMed Web of Science ®Google Scholar
• Schultheiss TE, Kun LE, Ang KK, et al. Radiation response of the central nervous system. Int J Radiat Oncol. 1995;31(5):1093–1112.
   PubMed Web of Science ®Google Scholar
• Sahgal A, Weinberg V, Ma L, et al. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol. 2013;85(2):341–347.
   PubMed Web of Science ®Google Scholar
• Bedford JL, Thomas MDR, Smyth G. Beam modeling and VMAT performance with the agility 160-leaf multileaf collimator. J Appl Clin Med Phys. 2013;14(2):172–185.
   Web of Science ®Google Scholar
• Wu QJ, Yoo S, Kirkpatrick JP, et al. Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment. Int J Radiat Oncol. 2009;75(5):1596–1604.
   PubMed Web of Science ®Google Scholar
• Li W, Sahgal A, Foote M, et al. Impact of immobilization on intrafraction motion for spine stereotactic body radiotherapy using cone beam computed tomography. Int J Radiat Oncol. 2012;84(2):520–526.
   PubMed Web of Science ®Google Scholar